|
Video: What is a Stock Split?
|
|
AIM ImmunoTech is a pharmaceutical company. Co. is engaged in the development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders. Co.'s primary products include: Alferon N Injection® and the experimental therapeutic Ampligen®. Alferon N Injection® is approved for a category of sexually transmitted disease infection, and Ampligen® represents an experimental RNA being developed for viral diseases and disorders of the immune system. Co.'s platform technology includes components for potential treatment of various severely debilitating and life threatening diseases. According to our HEB stock split history records, HEB has had 2 splits. | |
|
HEB (HEB) has 2 splits in our HEB stock split history database. The first split for HEB took place on August 29, 2016. This was a 1 for 12 reverse split, meaning for each 12 shares of HEB owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 83.3333333333333 share position following the split. HEB's second split took place on June 11, 2019. This was a 1 for 44 reverse split, meaning for each 44 shares of HEB owned pre-split, the shareholder now owned 1 share. For example, a 83.3333333333333 share position pre-split, became a 1.89393939393939 share position following the split.
When a company such as HEB conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the HEB stock split history from start to finish, an original position size of 1000 shares would have turned into 1.89393939393939 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into HEB shares, starting with a $10,000 purchase of HEB, presented on a split-history-adjusted basis factoring in the complete HEB stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/28/2014 |
|
End date: |
08/30/2019 |
|
Start price/share: |
$184.80 |
|
End price/share: |
$1.80 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.03% |
|
Average Annual Total Return: |
-57.98% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$97.35 |
|
Years: |
5.34 |
|
|
|
Date |
Ratio |
08/29/2016 | 1 for 12 | 06/11/2019 | 1 for 44 |
|
|